Gel Column Agglutination Test System Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 5.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Gel Column Agglutination Test System Market Analysis
The gel column agglutination test system market is expected to register a CAGR of 5.5% during the forecast period. Health awareness among the population and high health expenditure by the government are some of the factors driving the overall market. The gel column agglutination test gives high accuracy and more rapid results that will further lead to the adoption of these tests and boost the revenue growth of the market. These tests are widely used in the pharmaceutical industry for diagnostic purposes. Moreover, several applications in the field of research laboratories are also propelling the market as these tests are easy to conduct, the basic principle is being used wherein based on the size, the gel column separates agglutinated blood from non-agglutinated red blood cells leading to the high demand of this systems in the laboratories. Furthermore, technological advancements, increasing diagnostic centers, and hospital blood bank assists may also contribute to the gel column agglutination test market.
Gel Column Agglutination Test System Market Trends
This section covers the major market trends shaping the Gel Column Agglutination Test System Market according to our research experts:
Benchtop Segment is Expected to Hold largest Market Share in the Gel Column Agglutination Test System market
The Benchtop gel column agglutination system is expected to hold the largest share attributing to its convenience, ease of use with a faster performance which promotes the adoption of these types for testing in the pharmaceutical industries. Gel Column agglutination test system comprises several tests such as antibody screening, Serology test, direct antiglobulin test (DAT), RH type test, ABO test which is extensively used for diagnostic purposes and has been major factors for the segment growth.
In addition, with the increasing R&D expenditure worldwide, and several applications with this system such as blood grouping, red cell antibody detection, and identification and other serological applications, results in propelling the growth of the gel column agglutination test system market.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major market share in the global gel column agglutination test system market due to the growing number of diagnostic centers and high health awareness in this region. Moreover, technological advancements in the gel column agglutination testing system are leading to the increasing adoption of these testing methods which further lead to dominant the market in this region. Furthermore, increasing healthcare expenditure and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.
Gel Column Agglutination Test System Industry Overview
The market studied is moderately competitive and there are several international companies that are having an active presence in this market. Some of the companies which are currently gaining attention include, Bio-Rad Laboratories, Inc., Grifols, QIAGEN, Ortho Clinical Diagnostics, Tulip Diagnostics (P) Ltd, Thermo Fisher Scientific, 3B scientific and Mira Vista Labs.
Gel Column Agglutination Test System Market Leaders
-
QIAGEN
-
Ortho Clinical Diagnostics
-
Grifols
-
Bio-Rad Laboratories, Inc.
-
Tulip Diagnostics (P) Ltd
*Disclaimer: Major Players sorted in no particular order
Gel Column Agglutination Test System Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Assumptions
-
1.2 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Health Awareness and High Health Expenditure
-
4.2.2 High Accuracy and Rapid Results
-
-
4.3 Market Restraints
-
4.3.1 Cost Effectiveness
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Test Type
-
5.1.1 Antibody Screening
-
5.1.2 Serology Test
-
5.1.3 DAT
-
5.1.4 Others
-
-
5.2 By Type
-
5.2.1 Portable
-
5.2.2 Bench-Top
-
-
5.3 By End-User
-
5.3.1 Pharmaceuticals Industry
-
5.3.2 Hospital Blood Banks
-
5.3.3 Diagnostic Centers
-
-
5.4 Geography
-
5.4.1 North America
-
5.4.1.1 United States
-
5.4.1.2 Canada
-
5.4.1.3 Mexico
-
-
5.4.2 Europe
-
5.4.2.1 Germany
-
5.4.2.2 United Kingdom
-
5.4.2.3 France
-
5.4.2.4 Italy
-
5.4.2.5 Spain
-
5.4.2.6 Rest of Europe
-
-
5.4.3 Asia-Pacific
-
5.4.3.1 China
-
5.4.3.2 Japan
-
5.4.3.3 India
-
5.4.3.4 Australia
-
5.4.3.5 South Korea
-
5.4.3.6 Rest of Asia-Pacific
-
-
5.4.4 Middle-East and Africa
-
5.4.4.1 GCC
-
5.4.4.2 South Africa
-
5.4.4.3 Rest of Middle-East and Africa
-
-
5.4.5 South America
-
5.4.5.1 Brazil
-
5.4.5.2 Argentina
-
5.4.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Bio-Rad Laboratories Inc.
-
6.1.2 Ortho Clinical Diagnostics
-
6.1.3 QIAGEN NV
-
6.1.4 Grifols
-
6.1.5 Tulip Diagnostics (P) Ltd
-
6.1.6 Thermo Fisher Scientific
-
6.1.7 3B scientific
-
6.1.8 Mira Vista Labs
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Gel Column Agglutination Test System Industry Segmentation
Gel column agglutination test system is an automated technology that works on the gel column which acts as a filter that separates agglutinated red blood cells in the centrifugation. These systems are used for diagnostic and pharmaceutical industries.
| By Test Type | |
| Antibody Screening | |
| Serology Test | |
| DAT | |
| Others |
| By Type | |
| Portable | |
| Bench-Top |
| By End-User | |
| Pharmaceuticals Industry | |
| Hospital Blood Banks | |
| Diagnostic Centers |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Gel Column Agglutination Test System Market Research FAQs
What is the current Gel Column Agglutination Test System Market size?
The Gel Column Agglutination Test System Market is projected to register a CAGR of 5.5% during the forecast period (2024-2029)
Who are the key players in Gel Column Agglutination Test System Market?
QIAGEN, Ortho Clinical Diagnostics, Grifols, Bio-Rad Laboratories, Inc. and Tulip Diagnostics (P) Ltd are the major companies operating in the Gel Column Agglutination Test System Market.
Which is the fastest growing region in Gel Column Agglutination Test System Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Gel Column Agglutination Test System Market?
In 2024, the North America accounts for the largest market share in Gel Column Agglutination Test System Market.
What years does this Gel Column Agglutination Test System Market cover?
The report covers the Gel Column Agglutination Test System Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Gel Column Agglutination Test System Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Gel Column Agglutination Test System Industry Report
Statistics for the 2024 Gel Column Agglutination Test system market market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Gel Column Agglutination Test system market analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
